TargED Biopharmaceuticals B.V. is a spin-off from the University Medical Center Utrecht founded in July 2020, that develops innovative biological drugs to improve the treatment of thrombosis. The company is developing a first-in-class proprietary clot-busting compound, Microlyse, for improved thrombolysis as a treatment for acquired thrombotic thrombocytopenic purpura (aTTP) and Acute Ischemic Stroke (AIS). The groundbreaking work demonstrates that Microlyse specifically targets blood clots leading to their dissolution faster and safer compared to the standard of care, recently featured on the cover of the journal Blood (Microlyse: a thrombolytic agent that targets VWF for clearance of microvascular thrombosis).
Website
Location: Netherlands, Utrecht
Employees: 1-10
Total raised: $44.28M
Founded date: 2018
Investors 5
| Date | Name | Website |
| - | Curie Capi... | curiecapit... |
| - | Fund+ | fundplus.b... |
| - | Andera Par... | anderapart... |
| - | Utrecht Ho... | utrechthol... |
| 08.03.2022 | Hadean Ven... | hadeanvent... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 24.02.2022 | Series A | $44.28M | - |
Mentions in press and media 7
| Date | Title | Description | Source |
| 21.12.2023 | Hadean Ventures announces oversubscribed final close of Hade... | Hadean Ventures announces oversubscribed final close of Hadean Capital II – a fund dedicated to inve... | hadeanvent... |
| 30.12.2022 | Dutch-based biotech and life sciences startups that raised f... | The Netherlands is swiftly rising to the top as a hub for healthcare and life sciences innovation. M... | siliconcan... |
| 24.02.2022 | Utrecht-based TargED Biopharmaceuticals raises €39M, to targ... | TargED Biopharmaceuticals, an Utrecht-based biotechnology company focused on developing improved tre... | siliconcan... |
| 22.02.2022 | TargED Biopharmaceuticals raises EUR 39 Million in Series A ... | TargED Biopharmaceuticals raises EUR 39 Million in Series A financing to bring groundbreaking throm... | hadeanvent... |
| 22.02.2022 | TargED Biopharmaceuticals raises EUR 39 Million in Series A ... | TargED Biopharmaceuticals raises EUR 39 Million in Series A financing to bring groundbreaking thromb... | fundplus.b... |
| 22.02.2022 | Andera Partners supports TargED Biopharmaceuticals in €39 mi... | TargED Biopharmaceuticals (“TargED”), a private biotechnology company focused on developing improved... | anderapart... |
| 22.02.2022 | TargED Biopharmaceuticals Raises €39M in Series A Financing... | TargED Biopharmaceutical, a Utrecht, The Netherlands-based private biotechnology company focused on ... | finsmes.co... |